首页> 外文期刊>Stem cells and development >Recent Advances in Stem Cell Research in Subarachnoid Hemorrhage
【24h】

Recent Advances in Stem Cell Research in Subarachnoid Hemorrhage

机译:蛛网膜下腔出血干细胞研究的最新进展

获取原文
获取原文并翻译 | 示例
           

摘要

Subarachnoid hemorrhage (SAH) is a type of hemorrhagic stroke with significant morbidity and mortality, and it often leads to poor clinical outcome. Although great efforts have been made toward animal and clinical studies, optimal therapy of SAH remains a challenge for scientists and clinicians. Increasing evidence suggests that stem-cell-based therapies may provide innovative approaches for treatment of SAH-related disability. In this review, we summarized the recent advances in stem cell research in SAH. Neuroregeneration after SAH could be conducted by the activation of endogenous neural stem cells (NSCs), transplantation of external stem cells, or reprogramming non-neuronal cell to neurons. The potential mechanism and signaling pathways, as well as the efficiency and safety of these stem cell treatments, were discussed in detail. Although lots of challenges remain for translating the laboratory findings and technologies into clinical therapies, these research studies provided the foundation and guidance for using different resources of stem cells as a brain repair strategy after SAH.
机译:蛛网膜下腔出血(SAH)是一种出血性中风,具有显着的发病率和死亡率,并且通常导致临床结果不佳。虽然已经对动物和临床研究进行了巨大努力,但SAH的最佳治疗仍然是科学家和临床医生的挑战。越来越多的证据表明,基于干细胞的疗法可以为治疗SAH相关残疾提供创新方法。在本综述中,我们总结了SAH中最近干细胞研究的进展。在SAH之后的神经元素可以通过活化内源性神经干细胞(NSCs),外部干细胞移植或重编程非神经元细胞进行神经元进行。详细讨论了潜在的机制和信号传导途径,以及这些干细胞处理的效率和安全性。虽然将实验室调查结果和技术转化为临床疗法,但这些研究研究仍然仍然存在很多挑战,但这些研究研究提供了在SAH后使用不同资源的干细胞的不同资源的基础和指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号